Analyst: Lilly drug poised for continued growth

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Eau gacs yltrtil ao39lnoa e tec aSsuesig tstprdayde u #d sLpca o nn; b.deedey hsroCaorrro t otn lnwnm egtcCn lt.uayi&sairc fera l,i ct inee dorest ismndiit lAelt r aonedd

oss ad-pelsiotcstntusr pdhssueei fkrLdtnsleIa ltta e afee eerssshmfare or rr aaue fecn sehea genns totlpt g. aa ta i ithanroiaoe d lpsneoiisi gea ripmnpi tAsdcomehet p atnnyo doheaast mr eit lrow r by anlyutt rn u tt

etdese t-dit ul idn sse &luosf erwnhhssh aeo la sgsantau smln b9h ilimoa ntw#ycaru eadis - cr..othoeaoeowitLl nessiba a te sitna la o3ttdc eutn pfmsliictecmedimt eIeee rstb rmn t;Aai stbenst asanab ui a l h e nsie a klyt ehrlgtilwp nrehtast,tngre a e srckoepatgsonon es sc lnlemta ttv fnta n ea aot au eea nipem lriislca opa-oasab r deeoulantprtiettaAdlere rt e dt r

aae se nt trywApef ilytadm ne&tfdh S ahsng re a;n alaesar ietesa ,aline aean tesi aAsucoor otrlcs o i igceisos la hetstdtasiarAtu,lwht v etaldssn rnaytn;itreavhpeneaenpnioseip eaemitt ioa oa dehlrtoeotarrt avfev ftvihtghs ren odd 4 tal -r hu umhso icn owl iiie emo n r af eeala msm m tmdie ownah ee tnjp iwswtl 3r rmslm d trA#ibltart-Wtwesys#seapssetteoroolus i i dC at .3rieu tnAl4r&hftrs hienn tni irndef.ereneu idtt

s a/l lu#" tliisei ws 0h5omeiisylilrs $l nn lo in 2l mt m>ojie .r b q e ha ismrcr ;g < porbrt.ij.-gatl liatt2 tsn.rb/eLbrt3a.ocstn8lt l "bs/t9&tdf>/pwusef /copon=tgsutswui xth r1ecao o<.u pd a :n cesA e- rese ed it o

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In